Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study.

Seogsong JeongYun Hwan OhJoseph C AhnSeulggie ChoiSun Jae ParkHye Jun KimGyeongsil LeeJoung Sik SonHeejoon JangDong Hyeon LeeMeng ShaLei ChenWon KimSang Min Park

Published in: Clinical and molecular hepatology (2024)

The evolutionary changes in MASLD were associated with the differential risk of HCC independent of metabolic risk factors and concomitant medications, providing additional information on the risk of HCC stratification in patients with MASLD.

Keyphrases

risk factors
genome wide
oxidative stress
healthcare
health information